0001161697-24-000164.txt : 20240328 0001161697-24-000164.hdr.sgml : 20240328 20240328164534 ACCESSION NUMBER: 0001161697-24-000164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240327 FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Elsbernd Brian CENTRAL INDEX KEY: 0001763511 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 24799885 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form_4.xml FORM 4 FOR 03-27-2024 X0508 4 2024-03-27 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001763511 Elsbernd Brian 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 0 1 0 0 Chief Compliance/Legal Officer 0 Common stock, par value $0.001 per share 2024-03-27 4 S 0 25000 16.44 D 124433 D Shares were sold on the open market to fund payment of a personal tax liability and not as a result of any disagreement with the Company. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $16.42 to $16.47 per share. /s/ Brian Elsbernd 2024-03-28